Schizophrenia Clinical Trials

Showing 261-280 of 661 trials

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

NCT00946348

The first aim of this study is to determine whether a brain reward center (BRC) deficiency in patients with schizophrenia (SCZ) and cannabis use disorder (CUD) will be normalized when patients are given cannabis or dronabinol. The second aim will serve to further assess the effects of dronabinol on symptoms and medication side effects in this population.

SchizophreniaDual DiagnosisSchizoaffective Disorder+2 more

Dartmouth-Hitchcock Medical Center12 participantsStarted Dec 2009

Lebanon, New Hampshire, United States

COMPLETEDPHASE2

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

NCT01655680

This is a safety and efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.

Schizophrenia

AbbVie (prior sponsor, Abbott)432 participantsStarted May 2012

Anaheim, California, United States • Bellflower, California, United States • Chino, California, United States +58 more locations

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Related Searches

Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

Motivational Interviewing in Patients With Schizophrenia

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric Disorders

RCT of tDCS Combined With Cognitive Training in Schizophrenia

Familial Schizophrenia and Spectrum Personality Disorders

Bio-equivalence Study Between SAPHRIS and Asenapine

Treating Refractory Schizophrenia With rTMS

A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects

Assessing a WeChat-based Integrative Family Intervention (WIFI) for Schizophrenia

A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

MEtformin and Lorcaserin for WeighT Loss in Schizophrenia

Lurasidone Effects on Tissue Glutamate in Schizophrenia